Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 725Lymphoma, Non-Hodgkin 657Precursor Cell Lymphoblastic Leukemia-Lymphoma 583Leukemia, Lymphocytic, Chronic, B-Cell 555Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 418Lymphoma, Mantle-Cell 345Burkitt Lymphoma 306Leukemia 303Leukemia, Myeloid, Acute 297Hodgkin Disease 293Lymphoma, B-Cell 280Lymphoma, B-Cell, Marginal Zone 267Recurrence 246Multiple Myeloma 205Neoplasms 199Lymphoma, T-Cell, Cutaneous 171Myelodysplastic Syndromes 170Lymphoma, Large-Cell, Immunoblastic 160Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 159Waldenstrom Macroglobulinemia 146Lymphoma, Large-Cell, Anaplastic 142Mycosis Fungoides 132Sezary Syndrome 119Immunoblastic Lymphadenopathy 108Blast Crisis 92Hematologic Neoplasms 91Lymphoma, T-Cell, Peripheral 86Leukemia, Myelogenous, Chronic, BCR-ABL Positive 86Lymphoma, T-Cell 82

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Fasting × Lymphoid × Clear all
NCT04877080 2023-02-10

CD19 and BCMA Targeted Fast Dual CAR-T for CD19+ Refractory/Relapsed B-NHL

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Phase 1 Withdrawn
Lymphoid

Fasting, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡